Transcranial Magnetic Stimulation (TMS) is one of the safest and most effective treatments for major depression. The FDA has approved it to treat teenagers and adults but only for a time-limited course of care. For most people, that is all the treatment they need. For others, they require maintenance (continuation) TMS. This article reviews the research and rationale that shows the need for the FDA to approve maintenance TMS now.

The FDA got it right when they approved TMS therapy for adolescent depression (kids aged 15 and older). TMS is one of the most effective treatments for resistant depression. The decision to approve this treatment for kids is an absolute game-changer and will save many young lives. This article describes the dramatic impact of the FDA’s approval and covers research that shows TMS for kids to be safe, well-tolerated, and effective.

Even though depression rates for youth are rising, the FDA has only approved a few treatments for adolescent depression and has not yet approved TMS for adolescent depression. This article describes TMS for adolescents and covers research that shows TMS for kids to be safe, feasible, and likely effective.

Transcranial Magnetic Stimulation (TMS) therapy is one of the newest and most effective treatments for major depression, especially treatment-resistant depression. This article reviews recent research that supports Stanford’s revolutionary approach, which may improve the effectiveness and accessibility of TMS for depression.

Many people with longstanding depression believe that they have tried every treatment out there. A detailed review of their history often reveals that they are mistaken and that there are several strategies that they have never tried. This article addresses what information is needed to make a well-informed decision about what treatment to try next and how a history of past treatments combined with a strategic, methodical approach can open up options to newer and potentially more effective treatments.